Differential susceptibility of retroviruses to nucleoside analogues. - Wikidata - awgldk - TriplyDB

Differential susceptibility of retroviruses to nucleoside analogues.

Differential susceptibility of retroviruses to nucleoside analogues.

http://www.wikidata.org/entity/Q34349394

about

Reconstitution of an infectious human endogenous retrovirus Identification of a novel sulfonamide non-nucleoside reverse transcriptase inhibitor by a phenotypic HIV-1 full replication assay Potential of zoonotic transmission of non-primate foamy viruses to humans.Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase.Zidovudine and Lamivudine for HIV Infection.Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences Comprehensive in vitro analysis of simian retrovirus type 4 susceptibility to antiretroviral agents Molecular biology of foamy viruses.Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases AZT-resistant foamy virus.AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP.Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System.AZT resistance alters enzymatic properties and creates an ATP-binding site in SFVmac reverse transcriptase.

P2860

Q21559512-2E48CCE2-48D4-4119-8903-CA096B533182 Q28534728-E35CC7E6-8910-486B-ABB8-62ECEB3BF5CF Q30336260-CFE54DCE-A2DA-4D17-87BA-EBA2D2D774EE Q33877299-480596C8-E04C-441E-B014-B024162BC3CB Q34128479-925E3559-C508-4A1E-B1B4-FF65888D9ED9 Q34186095-8470193C-0890-4A2B-A0FF-CB51A3D17225 Q34194561-B7BC3885-D3D0-4A4A-AA99-3CBE2B1D204A Q35758600-A8C7D52F-683A-4E39-BC27-F038549C7410 Q36760224-3D47EA91-93CF-4E04-914E-50E2B069548A Q37743255-22E8CB4B-D392-4A9E-AEDF-81A891532DEB Q39525135-0A13B24E-1F28-49D9-B7B5-450C53AAFDC0 Q40074663-79578918-ADA6-47FF-A4EB-B18975571D6A Q41878118-A0225E7A-8D06-4FFB-804D-BC1CE50CCA39 Q41961457-92EAE28C-AB70-4A6C-81D3-5A0E64D7A7E1 Q42152706-BE56B8DC-EAB4-42DB-A64F-51D72183121B

P2860

Differential susceptibility of retroviruses to nucleoside analogues.

http://www.wikidata.org/entity/Q34349394

description

2001 nî lūn-bûn

@nan

2001 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մարտին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Differential susceptibility of retroviruses to nucleoside analogues.

@ast

Differential susceptibility of retroviruses to nucleoside analogues.

@en

Differential susceptibility of retroviruses to nucleoside analogues.

@nl

type

label

Differential susceptibility of retroviruses to nucleoside analogues.

@ast

Differential susceptibility of retroviruses to nucleoside analogues.

@en

Differential susceptibility of retroviruses to nucleoside analogues.

@nl

prefLabel

Differential susceptibility of retroviruses to nucleoside analogues.

@ast

Differential susceptibility of retroviruses to nucleoside analogues.

@en

Differential susceptibility of retroviruses to nucleoside analogues.

@nl

P1433

Q34349394-257CB1E9-BBCC-4416-9BB0-57095AAF5A07

P1476

Q34349394-81AEA5DF-BADC-41D5-B6F7-E7F42069501A

P2093

Q34349394-187CF28D-02A8-4B17-96F1-805253FE6E23

Q34349394-1B58D7FE-3408-4167-9DD0-E63A5D500DF6

Q34349394-1BFD0EEB-B57D-4BC7-A8E9-73DBF736D8BA

Q34349394-31D98886-C774-4E49-B9F9-FAEC996C8CCF

Q34349394-936CA65A-4DBC-4EC3-AF71-46C363B84F0C

Q34349394-B8AE55F7-C166-47BD-BFD6-FF0A4AC94600

Q34349394-D1E49503-69BE-4CC7-A30A-BBB0D31710AB

Q34349394-D578F021-F7A5-4ECF-8C80-7D0AB85AE740

Q34349394-DEB399CE-0CBD-44F4-993B-DD81E7D24031

P2860

Q34349394-03B89486-02D1-4669-987E-C83196946F17

Q34349394-0E56BF71-6520-4EA9-97B8-3D1D778EB38C

Q34349394-171069BE-6ED4-4B77-9049-1FCD585B94E4

Q34349394-1BAE3F04-9B65-4556-BE21-340F8D8EE630

Q34349394-1C1DD18A-3C9F-4867-91E0-F3E5372C67FF

Q34349394-23869032-F184-42FE-96DE-BD2BCDB18B63

Q34349394-270C1E14-D449-43FC-8976-666B47EF7A71

Q34349394-3902C6E8-6042-4BE3-9127-D7AA1B37C49E

Q34349394-40F94427-6054-445F-8F92-921DB7F2F3C8

Q34349394-468A3EA9-1A2A-490F-AF8C-96D9DD4D0EB1

P304

Q34349394-481D98BC-7437-4C7D-9696-C5E8D44B8592

P31

Q34349394-40D126AA-CF39-409F-A756-40BB4BB24FF2

P356

Q34349394-7B3BC0D4-4FD6-452D-AB9A-3167C11F5AB4

P433

Q34349394-DC5F66A0-E3A0-4886-8761-18F060E7E2FF

P478

Q34349394-74471296-59B1-432E-B7BE-A47E1E61AF35

P577

Q34349394-A9FBDEFF-E000-4872-851E-6C9848C901D9

P5875

Q34349394-D10CAFA4-BE2F-4F2C-AA36-2DC100E9A878

P698

Q34349394-1770F77D-4564-4684-B733-2E6B240EE64C

P356

095632020101200202

P1433

Antiviral Chemistry & Chemotherapy

P1476

Differential susceptibility of retroviruses to nucleoside analogues.

@en

P2093

A J Frater

http://www.w3.org/2001/XMLSchema#string

A R Grigg

http://www.w3.org/2001/XMLSchema#string

C L Hill

http://www.w3.org/2001/XMLSchema#string

D Cain

http://www.w3.org/2001/XMLSchema#string

G Patton

http://www.w3.org/2001/XMLSchema#string

J R Clarke

http://www.w3.org/2001/XMLSchema#string

L L Rosenblum

http://www.w3.org/2001/XMLSchema#string

M O McClure

http://www.w3.org/2001/XMLSchema#string

O Erlwein

http://www.w3.org/2001/XMLSchema#string

P2860

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS

In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV)

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

P304

91-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/095632020101200202

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11819020

http://www.w3.org/2001/XMLSchema#string

P698

11527046

http://www.w3.org/2001/XMLSchema#string